Pia Ease
Vice President, Investor Relations and Strategy
Replay available
Arcus Biosciences, Inc. (NYSE: RCUS) Q2 2024 earnings conference call, held 2024-08-08. Replay captured from the company's public earnings webcast.

Vice President, Investor Relations and Strategy
President and Chief Executive Officer
Chief Operating Officer
Chief Financial Officer
Chief Medical Officer
President
Watch the replay and follow the connected company analysis, news, and investor updates for Arcus Biosciences, Inc..
WEBVTT 00:00:00.031 -- 00:00:04.496 Good afternoon. Thank you for attending today's Arcus Biosciences second quarter 2024 00:00:04.496 -- 00:00:09.321 earnings call. My name is Tamia and I will be your moderator for today's call. 00:00:09.321 -- 00:00:12.784 All lines will be muted during the presentation portion of the call with an opportunity 00:00:12.784 -- 00:00:16.768 for questions and answers at the end. If you would like to ask a question, please press 00:00:16.768 -- 00:00:20.652 star one on your telephone keypad. I would now like to pass the conference over to your 00:00:20.652 -- 00:00:24.676 host, Pia Ease, Vice President of Investor Relations and Strategy. 00:00:24.676 -- 00:00:26.937 You may proceed. 00:00:27.588 -- 00:00:31.992 Hello everyone and thank you for joining us on today's conference call to discuss ARCIS' 00:00:31.992 -- 00:00:36.075 second quarter 2024 financial results and pipeline updates. 00:00:36.075 -- 00:00:40.239 I'd like to remind you that on this call, management will make forward-looking statements, 00:00:40.239 -- 00:00:44.723 including statements about our cash runway and our expected clinical development milestones 00:00:44.723 -- 00:00:49.747 and timelines. All statements, other than historical facts, reflect the current beliefs 00:00:49.747 -- 00:00:53.991 and expectations of management and involve risks and uncertainties that may cause our 00:00:53.991 -- 00:00:56.714 actual results to differ from those expressed. 00:00:56.714 -- 00:01:01.080 Those risks and uncertainties are described in our most recent annual report on Form 00:01:01.080 -- 00:01:06.767 10-K and quarterly report on Form 10-Q that have been filed with the SEC. 00:01:06.767 -- 00:01:09.571 We strongly encourage you to review our filings. 00:01:09.571 -- 00:01:1...